Cytokinetics, Inc. (CYTK)
61.23
-1.10
(-1.76%)
USD |
NASDAQ |
Oct 23, 16:00
61.23
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Price : 61.23 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 62.01 | 62.44 | 60.89 | 61.23 | 985633.0 |
| Oct 22, 2026 | 63.01 | 64.07 | 61.94 | 62.33 | 2.061M |
| Oct 21, 2026 | 64.30 | 64.78 | 62.46 | 62.86 | 1.081M |
| Oct 20, 2026 | 63.13 | 64.76 | 62.88 | 63.95 | 1.050M |
| Oct 19, 2026 | 62.06 | 63.60 | 61.84 | 62.65 | 1.913M |
| Oct 16, 2026 | 63.90 | 63.90 | 61.68 | 61.95 | 1.205M |
| Oct 15, 2026 | 64.81 | 65.57 | 63.81 | 63.92 | 1.665M |
| Oct 14, 2026 | 61.62 | 64.01 | 60.99 | 63.43 | 2.096M |
| Oct 13, 2026 | 62.32 | 63.05 | 61.50 | 61.62 | 1.936M |
| Oct 12, 2026 | 62.48 | 63.50 | 62.13 | 62.79 | 1.254M |
| Oct 09, 2026 | 61.87 | 63.03 | 61.59 | 62.91 | 1.118M |
| Oct 08, 2026 | 60.31 | 62.79 | 59.78 | 62.01 | 2.595M |
| Oct 07, 2026 | 61.08 | 62.05 | 60.15 | 61.12 | 2.396M |
| Oct 06, 2026 | 62.20 | 62.52 | 60.68 | 61.35 | 3.229M |
| Oct 05, 2026 | 65.60 | 65.76 | 62.19 | 62.70 | 3.234M |
| Oct 02, 2026 | 66.45 | 66.91 | 64.49 | 65.60 | 2.650M |
| Oct 01, 2026 | 65.73 | 67.27 | 65.30 | 65.62 | 1.724M |
| Sep 30, 2026 | 65.90 | 66.92 | 65.25 | 65.91 | 2.978M |
| Sep 29, 2026 | 65.91 | 66.52 | 64.38 | 65.64 | 2.402M |
| Sep 28, 2026 | 64.58 | 66.41 | 64.25 | 66.16 | 2.551M |
| Sep 25, 2026 | 65.66 | 65.94 | 64.44 | 64.66 | 1.599M |
| Sep 24, 2026 | 65.37 | 66.47 | 64.89 | 65.66 | 1.837M |
| Sep 23, 2026 | 67.02 | 67.38 | 64.72 | 65.81 | 2.051M |
| Sep 22, 2026 | 68.07 | 69.56 | 67.48 | 67.59 | 2.389M |
| Sep 21, 2026 | 69.30 | 69.50 | 67.35 | 67.56 | 1.603M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bristol Myers Squibb Co. | 61.48 |
| BridgeBio Pharma, Inc. | 68.56 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| BioMarin Pharmaceutical, Inc. | 55.95 |
| Exelixis, Inc. | 64.53 |
Price Related Metrics
| PS Ratio | 112.60 |
| PEG Ratio | -0.2066 |
| Earnings Yield | -11.80% |
| Market Cap | 8.496B |
| PEGY Ratio | -0.2066 |